Diabetes 51:356-365, 2002
© 2002 by the American Diabetes Association, Inc.
Indoleamine 2,3-Dioxygenase Expression in Transplanted NOD Islets Prolongs Graft Survival After Adoptive Transfer of Diabetogenic Splenocytes
Angela M. Alexander1,
Megan Crawford1,
Suzanne Bertera1,
William A. Rudert1,
Osamu Takikawa2,
Paul D. Robbins3, and
Massimo Trucco1
1 Division of Immunogenetics, Department of Pediatrics, Rangos Research Center, Childrens Hospital of Pittsburgh, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania
2 Department of Pharmacology, Hokkaido University, School of Medicine, Sapporo, Japan
3 Department of Molecular Genetics and Biochemistry, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania
Indoleamine 2,3-dioxygenase (IDO) catalyzes the breakdown of the amino acid tryptophan into kyneurenine. It has been shown that IDO production by placental trophoblasts prevents the attack of maternal T-cells activated in response to the paternal HLA alleles expressed by the tissues of the fetus. In this article, we show that adenoviral gene transfer of IDO to pancreatic islets can sufficiently deplete culture media of tryptophan and consequently inhibit the proliferation of T-cells in vitro. Experiments in vivo have also demonstrated that transplantation of IDO-expressing islets from prediabetic NOD mouse donors into NODscid recipient mice is associated with a prolongation in islet graft survival after adoptive transfer of NOD diabetogenic T-cells. This protection is attributed to the depletion of tryptophan at the transplantation site beneath the kidney capsule. These results suggest that local modulation of tryptophan catabolism may be a means of facilitating islet transplantation as a therapy for type 1 diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Cuffy, A. M. Silverio, L. Qin, Y. Wang, R. Eid, G. Brandacher, F. G. Lakkis, D. Fuchs, J. S. Pober, and G. Tellides
Induction of Indoleamine 2,3-Dioxygenase in Vascular Smooth Muscle Cells by Interferon-{gamma} Contributes to Medial Immunoprivilege
J. Immunol.,
October 15, 2007;
179(8):
5246 - 5254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mohib, Q. Guan, H. Diao, C. Du, and A. M. Jevnikar
Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells
Am J Physiol Renal Physiol,
September 1, 2007;
293(3):
F801 - F812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ueno, S. Cho, L. Cheng, J. Wang, S. Hou, H. Nakano, P. Santamaria, and Y. Yang
Transient Upregulation of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Human Chorionic Gonadotropin Downregulates Autoimmune Diabetes
Diabetes,
June 1, 2007;
56(6):
1686 - 1693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Liu, H. Dai, N. Wan, T. Wang, S. Bertera, M. Trucco, and Z. Dai
Suppression of Memory CD8 T Cell Generation and Function by Tryptophan Catabolism
J. Immunol.,
April 1, 2007;
178(7):
4260 - 4266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Sarkar, R. Wong, S. I. Hackl, O. Moua, R. G. Gill, A. Wiseman, H. W. Davidson, and J. C. Hutton
Induction of Indoleamine 2,3-Dioxygenase by Interferon-{gamma} in Human Islets
Diabetes,
January 1, 2007;
56(1):
72 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Seymour, V. Ganapathy, A. L. Mellor, and D. H. Munn
A high-affinity, tryptophan-selective amino acid transport system in human macrophages
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1320 - 1327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Agaugue, L. Perrin-Cocon, F. Coutant, P. Andre, and V. Lotteau
1-Methyl-Tryptophan Can Interfere with TLR Signaling in Dendritic Cells Independently of IDO Activity
J. Immunol.,
August 15, 2006;
177(4):
2061 - 2071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Meisel, A. Zibert, M. Laryea, U. Gobel, W. Daubener, and D. Dilloo
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
Blood,
June 15, 2004;
103(12):
4619 - 4621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Munn, M. D. Sharma, and A. L. Mellor
Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells
J. Immunol.,
April 1, 2004;
172(7):
4100 - 4110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Swanson, Y. Zheng, K. M. Heidler, T. Mizobuchi, and D. S. Wilkes
CDllc+ Cells Modulate Pulmonary Immune Responses by Production of Indoleamine 2,3-Dioxygenase
Am. J. Respir. Cell Mol. Biol.,
March 1, 2004;
30(3):
311 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Mellor and D. H. Munn
Tryptophan Catabolism and Regulation of Adaptive Immunity
J. Immunol.,
June 15, 2003;
170(12):
5809 - 5813.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bertera, M. L. Crawford, A. M. Alexander, G. D. Papworth, S. C. Watkins, P. D. Robbins, and M. Trucco
Gene Transfer of Manganese Superoxide Dismutase Extends Islet Graft Function in a Mouse Model of Autoimmune Diabetes
Diabetes,
February 1, 2003;
52(2):
387 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Munn, M. D. Sharma, J. R. Lee, K. G. Jhaver, T. S. Johnson, D. B. Keskin, B. Marshall, P. Chandler, S. J. Antonia, R. Burgess, et al.
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Science,
September 13, 2002;
297(5588):
1867 - 1870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bottino, A.N. Balamurugan, S. Bertera, M. Pietropaolo, M. Trucco, and J. D. Piganelli
Preservation of Human Islet Cell Functional Mass by Anti-Oxidative Action of a Novel SOD Mimic Compound
Diabetes,
August 1, 2002;
51(8):
2561 - 2567.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|